[Endoscopic treatment of the vesicoureteral reflux in children: preliminary experience with the subureteral injection of Coaptite].
OBJECTIVE
To review our experience in the endoscopic treatment of vesicoureteral reflux (VUR) in children with the subureteral injection of calcium hydroxyapatite (Coaptite).


METHODS
The serie includes thirteen children whose age ranged between 6 and 13 years. The Coaptite implant was injected subureterally to 20 ureteral units (UU) affected by VUR grades I-IV. VUR was unilateral in six patients (46%), bilateral in seven (54%). There were 7 primary cases and 6 secondary to bladder dysfunction and duplex systems.


RESULTS
Mean follow-up was 19 months (6-28 months). VUR was cured in 75% of cases after a single injection. A second injection resolved 2 out of 4 treated UU (50%) rendering a global success rate of 85%. This cure rate was achieved for 13 and 7 procedures treating primary and secondary VUR, respectively. 77% of patients reported no adverse events with only 23% of them complaining of transient mild lumbar and hypogastric discomfort limited to the first postoperative day. In 2 children postoperative urinary infection was detected.


CONCLUSIONS
Endoscopic subureteral injection with Coaptite is a simple technique well tolerated in children. In 85% of primary and secondary cases cure was achieved with minimal morbidity.
Mora Durbán
Miguel Julián
MJ
Servicio de Urología del Hospital Germans Trias i Pujol, Badalona, Barcelona, España. migueljmora@terra.es
Navarro Sebastián
Francisco Javier
FJ
Muñoz Delgado
María Belén
MB
García González
Jesús Isidoro
JI
Paniagua Andrés
Pedro Dionisio
PD
D000293:Adolescent; D001672:Biocompatible Materials / Q000008:administration & dosage*; D002648:Child; D017886:Durapatite / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007267:Injections; D008297:Male; D014513:Ureter; D018666:Ureteroscopy; D014718:Vesico-Ureteral Reflux / Q000628:therapy*
D001672:Biocompatible Materials; D017886:Durapatite